EUVIMEDEUVIMED entdecken
Crossref

Anti‐Canine Mammary Carcinoma Effects of mPP ‐Based Nano‐Micelles Encapsulating DPIA

Yuhong Chen iD, Han Wang, Zhenyu Wang, Yunyu Xie, Funeng Xu, Xiaoxia Liang

Veterinary and Comparative Oncology · 2026-12 · 24 (4) · 695-706

DOI: 10.1111/vco.70086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, online erschienen am 06.07.2026. Verfasst von Yuhong Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Natural Medicine Research Center, Department of Pharmacy, Sichuan Agricultural University, Chengdu, China. Hauptthemen laut MEDLINE: Mammary Neoplasms, Animal, Antineoplastic Agents, Dog Diseases. Die Arbeit nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple negative breast cancer (TNBC) presents a significant challenge in breast cancer treatment. Canine mammary carcinoma, characterized by spontaneous tumours in female dogs, serves as a robust spontaneous model for TNBC. In this study, DPIA, a potent antitumor agent, was encapsulated into synthesized mPEG‐PCL (mPP) to form nano‐micelles, aiming to enhance its in vivo therapeutic efficacy. DPIA@mPP exhibited more uniform dispersion and a spheroid‐like architecture, with a drug loading rate of 4.31% and an encapsulation rate of 13.10%. Both DPIA@mPP and free DPIA exhibited comparable and significant cytotoxicity against canine mammary carcinoma cells (CMT‐7364) in vitro. Encapsulation into mPP enhanced DPIA uptake by CMT‐7364 cells, increasing tumour inhibition from 30.31% to 48.55%, while markedly reducing in vivo toxicity. Overall, the DPIA@mPP group demonstrated superior in vivo antitumor efficacy and a good safety profile. Furthermore, preliminary mechanistic studies suggest that DPIA@mPP may promote apoptosis in CMT‐7364 cells, potentially through the inhibition of the PI3K/AKT signalling pathway, offering novel insights into TNBC treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mammary Neoplasms, AnimalAntineoplastic AgentsDog DiseasesAnimalsFemaleDogsMicellesPolyethylene GlycolsCell Line, TumorPolyestersNanoparticles

Stichwörter der Autor:innen

2‐phenylindole derivativesanti‐ canine mammary carcinoma effectsmPEG‐PCLnano‐micellestriple‐negative breast cancer

Substanzen

MicellesAntineoplastic AgentsPolyethylene Glycolsmethoxy poly(ethylene glycol-co-epsilon-caprolactone)Polyesters

Autor:innen und Institutionen

  • Natural Medicine Research Center, Department of Pharmacy, Sichuan Agricultural University, Chengdu, China.
  • Key Laboratory of Agricultural Bioinformatics, Ministry of Education, Sichuan Agricultural University, Chengdu, China.

ORCID-Profile: Yuhong Chen

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Sichuan Province

Zitieren

APA

Chen, Y., Wang, H., Wang, Z., Xie, Y., Xu, F., & Liang, X. (2026). Anti‐Canine Mammary Carcinoma Effects of mPP ‐Based Nano‐Micelles Encapsulating DPIA. Veterinary and Comparative Oncology, 24(4), 695-706. https://doi.org/10.1111/vco.70086

Vancouver

Chen Y, Wang H, Wang Z, Xie Y, Xu F, Liang X. Anti‐Canine Mammary Carcinoma Effects of mPP ‐Based Nano‐Micelles Encapsulating DPIA. Veterinary and Comparative Oncology. 2026;24(4):695-706. doi:10.1111/vco.70086

BibTeX
@article{Chen2026,
  author = {Chen, Yuhong and Wang, Han and Wang, Zhenyu and Xie, Yunyu and Xu, Funeng and Liang, Xiaoxia},
  title = {Anti‐Canine Mammary Carcinoma Effects of mPP ‐Based Nano‐Micelles Encapsulating DPIA},
  journal = {Veterinary and Comparative Oncology},
  year = {2026},
  volume = {24},
  number = {4},
  pages = {695--706},
  doi = {10.1111/vco.70086}
}
Kostenlos starten →